StockData
Cytokinetics Inc logo

Cytokinetics Inc (CYTK) stock

CYTKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30
$51.32−0.33 (-0.64%)

Close on Nov 18, 2026Market cap $7.13BP/E –Yield –

Cytokinetics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Cytokinetics's revenue for the twelve months ending Jun 30, 2026 was $67.67M, down 21.1% year over year. For fiscal 2025 it was $88.04M, up 376.6% from the year before. Over ten years it grew 11.9% a year on average. The highest annual figure on record is $106.41M in fiscal 2016.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$88.04M+376.6%
FY2024Dec 31, 2024$18.47M+145.3%
FY2023Dec 31, 2023$7.53M-92.0%
FY2022Dec 31, 2022$94.59M+34.3%
FY2021Dec 31, 2021$70.43M+26.2%
FY2020Dec 31, 2020$55.83M+107.8%
FY2019Dec 31, 2019$26.87M-14.7%
FY2018Dec 31, 2018$31.50M+135.6%
FY2017Dec 31, 2017$13.37M-87.4%
FY2016Dec 31, 2016$106.41M+271.3%
FY2015Dec 31, 2015$28.66M-38.9%
FY2014Dec 31, 2014$46.94M+53.2%
FY2013Dec 31, 2013$30.65M+305.5%
FY2012Dec 31, 2012$7.56M+89.0%
FY2011Dec 31, 2011$4.00M+55.2%
FY2010Dec 31, 2010$2.58M-96.8%
FY2009Dec 31, 2009$81.54M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$28.62M-57.1%
Q1 FY2026Mar 31, 2026$19.36M+1125.8%
Q4 FY2025Dec 31, 2025$17.76M+4.9%
Q3 FY2025Sep 30, 2025$1.94M+318.1%
Q2 FY2025Jun 30, 2025$66.77M+26714.9%
Q1 FY2025Mar 31, 2025$1.58M+89.1%
Q4 FY2024Dec 31, 2024$16.93M+912.4%
Q3 FY2024Sep 30, 2024$463.00K+22.5%
Q2 FY2024Jun 30, 2024$249.00K-71.3%
Q1 FY2024Mar 31, 2024$835.00K-81.9%
Q4 FY2023Dec 31, 2023$1.67M-14.6%
Q3 FY2023Sep 30, 2023$378.00K-85.0%
Q2 FY2023Jun 30, 2023$867.00K-99.0%
Q1 FY2023Mar 31, 2023$4.61M+301.8%
Q4 FY2022Dec 31, 2022$1.96M-96.5%
Q3 FY2022Sep 30, 2022$2.52M-53.7%
Q2 FY2022Jun 30, 2022$88.97M+3029.4%
Q1 FY2022Mar 31, 2022$1.15M-82.5%
Q4 FY2021Dec 31, 2021$55.60M+727.1%
Q3 FY2021Sep 30, 2021$5.44M-87.0%
Q2 FY2021Jun 30, 2021$2.84M-20.9%
Q1 FY2021Mar 31, 2021$6.55M+71.2%
Q4 FY2020Dec 31, 2020$6.72M+29.0%
Q3 FY2020Sep 30, 2020$41.69M+588.5%
Q2 FY2020Jun 30, 2020$3.59M-49.7%
Q1 FY2020Mar 31, 2020$3.83M-54.8%
Q4 FY2019Dec 31, 2019$5.21M-44.4%
Q3 FY2019Sep 30, 2019$6.06M-43.1%
Q2 FY2019Jun 30, 2019$7.14M+14.8%
Q1 FY2019Mar 31, 2019$8.46M+60.7%
Q4 FY2018Dec 31, 2018$9.38M–
Q3 FY2018Sep 30, 2018$10.64M+72.2%
Q2 FY2018Jun 30, 2018$6.22M+103.6%
Q1 FY2018Mar 31, 2018$5.27M+26.8%
Q4 FY2017Dec 31, 2017-$18.00K-100.1%
Q3 FY2017Sep 30, 2017$6.18M-89.5%
Q2 FY2017Jun 30, 2017$3.05M–
Q1 FY2017Mar 31, 2017$4.15M–
Q4 FY2016Dec 31, 2016$33.14M–
Q3 FY2016Sep 30, 2016$59.05M–

More Cytokinetics figures

See a number that looks wrong?